 - Adjuvant therapy: Beginning at least 28 days after surgical resection, patients with at least stable disease after completion of neoadjuvant therapy receive 4 courses of adjuvant bevacizumab, oxaliplatin, and capecitabine as in neoadjuvant therapy. 